NCT04846933View on ClinicalTrials.gov

Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC

NARecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions

High Grade Ovarian Serous AdenocarcinomaHigh Grade Serous Carcinoma

Interventions

GENETIC

WGS and RNA sequencing

GENETIC

circulating tumor DNA (ctDNA)

DIAGNOSTIC_TEST

FDG PET/CT imaging

Trial Locations (1)

20520

RECRUITING

Turku University Hospital, Turku

All Listed Sponsors

collaborator

University of Helsinki

OTHER

lead

Turku University Hospital

OTHER_GOV

NCT04846933 - Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC | Biotech Hunter | Biotech Hunter